New funding for GHGSat’s expansion of satellites to detect methane emissions, USask’s VIDO receives a $6-million award for vaccine development from an international epidemic coalition, Ontario and Ottawa make investments in livestock research, and more.
Organization: Pfizer Inc
SGC launches third phase with $49.9 million in funding
The Toronto-based Structural Genomics Consortium (SGC) has received $48.9 million to launch its third four-year phase. The funding is 30% less than in previous phases due primarily to the closure of the SGC laboratory at Karolinska Institutet in suburban Stockholm last June. The funding — 45% of which comes from commercial entities — will support…
Xenon Genetics seals major private placement
Xenon Genetics Inc has closed a $70-million private placement with an international syndicate of institutional, venture capital and pharmaceutical firms that it contends is the largest to date for an independent Canadian biotechnology firm. The funding will be used to advance its various drug discovery programs, develop its global network of clinical populations and databases,…
Applied PeR$pectives
Building with CCNB-INNOV… Relationships that go a Long Way! CCNB-INNOV, the applied research and development arm of CCNB has adapted its range of services to better meet the unique needs of the regional shipbuilding industry.
 |
Applied PeR$pectives is a new monthly blog dedicated to highlighting the innovative work being done in the college and institute community. |
|---|
Fast Policy Facts
 |
December 12, 2018: Requiem for a National Network Program
|
|---|
Research Money on Twitter
Loading tweets...